Research programme: monoclonal antibody therapeutics - Superview BiotechnologyAlternative Names: SBI-1205
Latest Information Update: 12 Mar 2014
At a glance
- Originator Superview Biotechnology
- Class Monoclonal antibodies
- Mechanism of Action Vascular endothelial growth factor A modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 12 Mar 2014 Preclinical trials in Cancer in China (Parenteral)